Skip to content
Search

Latest Stories

Inventor gifts tablet press to the University students

The equipment (Tablet Press Machine) can be used in pharmaceutical studies as well as metallurgy and 3D printing

Dr Michael Gamlen, the inventor of Gamlen instruments presents a tablet press machine to the students at the School of Pharmacy on 16 October.


The equipment not only solves the challenge of producing lab-scale tablets under precise conditions but also offers valuable insights into material compaction properties.

It is also known as a powder compaction analyser which has been given on loan to the University of Sunderland for five years.

2023pr127pic4 scaled The powder compaction analyser was gifted to University of Sunderland students' by Dr Michael Gamlen. Credit: David Wood

Dr Gamlen talks about the machine and how pharmacy students will benefit, saying: “It allows you to make tablets under tightly controlled conditions and enables you to make accurate comparisons between different materials and processes.

“The students will be able to easily see the impact of the tablet compaction conditions on tablet properties. This is very important to understand when developing new tablet formulations and manufacturing products.”

Dr Gamlen collaborated with Fette Compacting, a provider of integrated solutions for industrial tablet production in the pharmaceutical industry at the beginning of the year.

The technology has been adopted by major companies including Pfizer, GSK, Novartis and Novo Nordisk.

It can be used in pharmaceutical studies as well as metallurgy and 3D printing.

As a former student, Dr Gamlen specialised in Pharmaceutical Engineering and conducted a project focused on tablet granulation and compaction – and as a result, has been studying tabletting ever since.

2023pr127pic3 scaled Dr Michael Gamlen with his wife Alice Noon. Credit: David Wood

Later, he and his wife, Alice Noon, returned to the City campus to gift the tablet press to the university students.

The machine is used by various leading universities in the UK including Imperial College London, Rutgers University, MIT and Copenhagen University, confirmed Dr Gamlen.

“I wanted to make it available to the students at my academic birthplace in Sunderland,” he added.

“I was impressed by the University’s new facilities during my recent visit. To see modern labs and lecture theatres was very refreshing and I am sure it all provides a great learning experience for the students.

“I very much enjoyed my time in Sunderland and it’s great to be able to give something back,” said Dr Gamlen.

Dr Paul Carter, practising Community Pharmacist and Senior Lecturer in Pharmaceutical Sciences at the University, said: “Our School of Pharmacy has a very strong alumni association, and we are very grateful to Dr Gamlen for providing education and research opportunities for both undergraduates and postgraduate students.

“Our continued relationship means both staff and students are benefiting greatly from Dr Gamlen’s considerable experience and skills.

“We are always open to strengthening links with our alumni members; this is a great example of how the alumni network can support and help us progress in our teaching and research.”

In 2011, Dr Gamlen founded his own company – Gamlen Tableting Limited – and created the world’s first computer-controlled benchtop tablet press, which would lead to the conception of the Gamlen Powder Compaction Analyser; a groundbreaking instrument for the study of the entire compaction process of powdered materials.

More For You

Janet Morrison discusses pharmacy funding strategy at 2025 conference

Health Secretary Wes Streeting outlines government support for community pharmacy

CPE calls new funding deal a ‘reluctant yes’

Community Pharmacy England (CPE) was “reluctant” to accept the new pharmacy funding deal due to the significant funding gap, said the organisation’s chief executive Janet Morrison, while recognising the settlement as the first step towards stabilising the sector.

Addressing the 2025 Pharmacy Business Conference on Sunday at London Hilton Wembley, Janet shared insights into the behind-the-scenes work that led to the agreement.

Keep ReadingShow less
RPS transition to Royal College

RPS transition to Royal College: What it means for pharmacy

RPS transition to Royal College: What it means for pharmacy - Professor Claire Anderson explains

The Royal Pharmaceutical Society (RPS) is set to transition into a Royal College after securing majority support from its members in a recent ballot. However, concerns have been raised about the long-term implications of this shift.

With a voter turnout of 31.4%, 6,144 out of 19,594 eligible members participated in the vote on the Royal Charter changes. Of those, 71.1% supported the transition, well above the required two-thirds majority for a Special Resolution Vote.

Keep ReadingShow less
Pharmacies key to driving the shift from treatment to prevention

Bas Vorsteveld, Kenvue’s area managing director for Northern Europe.

Pharmacies can become frontline educators of self-care

Pharmacies have the potential to play a pivotal role in the government's transition from treatment-based healthcare to a more prevention-focused approach. However, for this shift to be successful, they require greater systemic support.

Bas Vorsteveld, Kenvue’s area managing director for Northern Europe, emphasises the importance of allowing pharmacists access to patient records to enable them to offer tailored advice and improve patient care.

Keep ReadingShow less
Community pharmacist consulting with a patient about independent prescribing.

Malcolm Harrison

Exclusive: National prescribing service 'critical' for community pharmacy, says Malcolm Harrison

A national prescribing service is “critical” for community pharmacy with all newly qualified pharmacists becoming independent prescribers from next year, according to Malcolm Harrison, chief executive of the Company Chemist Association (CCA).

“We are encouraging the NHS to work with community pharmacy to explore what that (prescribing service) could look like. There are pilots that are out there at the moment, and I know a number of pharmacies are engaged in those and exploring the different variations of what it could be,” Harrison told Pharmacy Business.

Keep ReadingShow less
Unlocking the potential of technology in pharmacy

Harry McQuillan, chairman, Numark

Technology in pharmacy goes beyond operational improvements

Community pharmacies are expected to take on greater responsibilities to ease pressure on other healthcare services and meet growing patient demands. However, despite their expanding role, they continue to lack adequate financial support.

“While funding negotiations continue, one thing remains clear, technology is key to ensuring pharmacy can thrive in a rapidly evolving healthcare landscape,” said Harry McQuillan, chairman of Numark.

Keep ReadingShow less